Under a final rule published in the Federal Register, the pain reliever tramadol is classified as a Schedule IV controlled substance (CS) starting August 18, 2014. Drug Enforcement Administration (DEA) will require manufacturers to print the “C-IV” designation on all labels that contain tramadol, including its salts, isomers, and salts of isomers.
More Latest News
August 5, 2021
Important Updates Regarding the Revised Emergency Use Authorization, Direct Order, and Reporting Process for REGEN-COV Monoclonal Antibody Therapy Continue reading